Fig. 1
From: Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
β-catenin expression in serum and tissue samples of HBV-related liver diseases. a ELISA analysis of serum β-catenin levels from healthy controls (HCs), healthy HBV carriers (HHCs) and patients with HBV-related liver diseases with different phases (CHB, HBLC and HCC). b IHC staining of β-catenin in representative biopsied liver samples from patients with CHB, HBLC and HCC. Blank scale bars = 100 µm. Data represents the mean ± SD. ***p < 0.001. Ns no statistical significance